Dr. Wadih Rhondali is a physician specialized in psychiatry and psycho-oncology, with over 13 years of clinical and academic experience in supportive and palliative care. He completed his medical training in France, where he conducted research on symptom assessment, patient–caregiver communication, and psychological adaptation in advanced cancer. He has contributed to several peer-reviewed publications in oncology, palliative care, and mental health.
Dr. Rhondali has worked in major cancer centers in France and Morocco, where he developed clinical programs integrating mental health approaches into oncology and survivorship care. He is a member of multiple professional societies in psychiatry, psycho-oncology and behavioral medicine, and has been involved in interdisciplinary initiatives promoting access to high-quality palliative care.
His current work focuses on the emotional, cognitive and existential dimensions of incurable cancer, the development of innovative models of supportive care, and the improvement of patient quality of life across the disease trajectory.
Dr. Wadih Rhondali is a physician specialized in psychiatry and psycho-oncology, with over 13 years of clinical and academic experience in supportive and palliative care. He completed his medical training in France, where he conducted research on symptom assessment, patient–caregiver communication, and psychological adaptation in advanced cancer. He has contributed to several peer-reviewed publications in oncology, palliative care, and mental health.
Dr. Rhondali has worked in major cancer centers in France and Morocco, where he developed clinical programs integrating mental health approaches into oncology and survivorship care. He is a member of multiple professional societies in psychiatry, psycho-oncology and behavioral medicine, and has been involved in interdisciplinary initiatives promoting access to high-quality palliative care.
His current work focuses on the emotional, cognitive and existential dimensions of incurable cancer, the development of innovative models of supportive care, and the improvement of patient quality of life across the disease trajectory.